CYC ASX Chart
Snapshot
Cyclopharm Limited (CYC) is engaged in manufacturing and selling of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -8.37% |
vs ASX 200 (1yr) | -19.22% |
Latest Cyclopharm Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Kingsgrove NSW 2208 |
Website | www.cyclopharm.com.au |
Registry | Automic Group |
Auditor | Nexia Sydney Audit Pty Ltd |
Date Listed | 18 Jan 2007 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/05/2024 | AGM |
20/08/2024 | Report (Interim) |
26/02/2025 | Report (Prelim) |
25/03/2025 | Report (Annual) |
Former Company Names
- Cyclopharm Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Key Data | |
---|---|
DPS(TTM) | $0.005 |
Gross DPS(TTM) | $0.005 |
Dividend yield |
|
Gross yield |
|
Payout Ratio | -- |
DRP | No |
DRP Features | -- |
Directors & Management
Directors
Management
Director Transactions
CYC directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of CYC directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Mr James McBrayer | 28/02/2023 | 5,109,580 | 5.49 |
CVC Limited | 28/02/2023 | 6,644,758 | 7.14 |
Barings Acceptance Limited | 28/02/2023 | 11,444,962 | 12.30 |
Anglo Australian Christtan and Charitable Fund | 28/02/2023 | 13,211,332 | 14.20 |
HSBC Custody Nominees (Australia) Limited A/C 2 | 28/02/2023 | 10,023,994 | 10.77 |
Chemical Overseas Limited | 28/02/2023 | 8,005,769 | 8.60 |
National Nominees Ltd | 28/02/2023 | 9,732,155 | 10.46 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $2.00 | 30 June |
2022 | $1.02 | 30 June |
2021 | $1.70 | 30 June |
2020 | $1.40 | 30 June |
2019 | $1.47 | 28 June |
2018 | $1.000 | 29 June |
2017 | $0.820 | 28 June |
2016 | $0.980 | 28 June |
2015 | $0.550 | 30 June |
2014 | $0.210 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.